To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT04893603

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Chengdu Silara Meditech Inc. (from the registry)
Registry
  • NCT NCT04893603
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04893603. Allocation not applicable; no masking; primary purpose treatment. Start 2020-12-16 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis
Condition
Aortic Valve Stenosis
Intervention (Device)
Transcatheter Aortic Valve System
Lead sponsor
Chengdu Silara Meditech Inc. (class: industry)

Record details

Record id
cardio:ct-nct04893603
Content hash
510bbe0d5cbae6458eace9f7c7ef05d7ea1882c76999bec5eaac8d2682d7b5b2